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ABSTRACT
It is well-recognized that diabetes-related complications are the leading cause of the still increased 
morbidity and mortality from diabetes and exert a heavy economic burden on society. The discovery of 
insulin led to a dramatic change in life expectancy of patients with type 1 diabetes (T1D). Furthermore, it 
caused a major shift in the distribution of causes of death - from diabetic coma in the pre-insulin era, to 
long-term complications being the predominant causes of death nowadays. The aim of the present review 
is to assess the trends in the absolute and the relative mortality rates as well as the leading causes of death 
among patients with childhood-onset (<18 years) T1D in populations from different latitudes. It is also 
observed how disease duration, age at diagnosis, and year of diagnosis affect these mortality trends. Eight 
population-based studies published in English in the last 14 years, as well as another one, published in 2001, 
with different duration of follow-up, are included in the review. However, it is hard to compare different 
populations due to the dissimilarities in the study methods and the characteristics of the examined cohorts.
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INTRODUCTION
Тype 1 diabetes (T1D) is the most common en-
docrine disorder and represents one of the most fre-
quent chronic diseases in children. Major studies 
have shown a significant decrease in mortality after 
the implementation of insulin therapy (1,2). In the 
Joslin Clinic in the United States, for example, mor-
tality rates have declined substantially for patients 
aged between 10 and 30 years - from 360-824/1000 
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frequent causes of early mortality in some countries 
(8,19,21,22).
The aim of the present review is to assess mor-
tality trends in subjects with childhood-onset T1D 
and to make comparisons with the general popula-
tion. Altogether, nine population-based studies are 
included. Five of them are long-term (≥14-year fol-
low-up), respectively those from Finland (5), Norway 
(8), USA (9, 14), and Japan (10). The cohort from Is-
rael (23) has a mean duration of follow-up of 14±8 
years. The T1D subjects in Allegheny County (Penn-
sylvania) are used as representative of the T1D pop-
ulation in the USA (9, 14). The studies from Sweden 
(24), Wales (25), and Northern Ireland (26) are with a 
shorter mean duration of follow-up - between 8 and 
12 years. The characteristics of the included studies 
are given in Table 1.
Absolute and Relative Mortality
Mortality is found to be similar in two of the 
countries with the highest incidence of T1D, Fin-
land and Sweden (27) - 2.45/1000 and 2.2/1000 per-
son-years for those diagnosed in 1970-1999 in Fin-
land and in 1973-1982 in Norway, respectively (5,8). 
The duration of follow-up for both cohorts is more 
than 20 years. Kenet et al. report lower rates of mor-
tality in their study from Israel (1.55/1000) including 
T1D subjects with a similar year of diagnosis to that 
of the cohorts from Finland and Norway (1965-1993) 
(23). Significantly higher mortality rates (more than 
person-years in 1897-1914 to 1.0-14.4/1000 in 1950-
1961 (1). However, T1D is still associated with con-
siderable premature mortality (3-8).
The geographic differences in mortality among 
patients with childhood-onset T1D are well-recog-
nized (8-11). The Diabetes Epidemiology Research 
International (DERI) mortality study shows the 
highest mortality rate in Japan despite the lowest in-
cidence of T1D there (12). According to another large 
study, mortality rates are the highest in Japan, Rus-
sia, and Eastern Europe, while individuals in Bulgar-
ia are 10 times more likely to die than those in Nor-
way prior to the age of 25 years (13). 
In contrast to earlier years, when the lead-
ing cause of death was diabetic ketoacidosis (DKA), 
long-term complications and particularly cardiovas-
cular and renal disease, are the predominant causes 
of mortality in T1D nowadays (14). Nevertheless, 
high levels of excess mortality are also observed in 
subjects with short duration of the disease without 
signs of chronic complications (15-19). Early mor-
tality is mainly associated with the development of 
DKA and severe hypoglycemia (7,8,20). On the other 
hand, the EURODIAB study reveals that only 35% of 
deaths in children diagnosed after 1989 and followed 
up for 7.6 years are due to acute diabetes complica-
tions, while another 53% of deaths are due to non-di-
abetes causes (accidents, suicide, etc.) (7). It is worth 










Final Year of 
Survey 
USA/Allegheny 
County 1075 <18 yrs 1965-1979 32±7.6 2008
Finland 10492 0-14 yrs 1970-1999 21.4 2007
Sweden 10200 0-14 yrs 1977-2000 8 not applicable
Norway 1906 0-14 yrs 1973-1982 24.2 2002
Japan 1385 <18 yrs 1965-1979 24.4±6.4 2005
Northern Ireland 3129 <15 yrs 1989-2012 12.1 2012
Wales 3642 <15 yrs 1981-2015 11.8 2015
Israel 1861 <17 yrs 1965-1993 14±8 1996
Table 1. Characteristics of the population-based studies
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6/1000) are observed among the T1D patients diag-
nosed from 1965 through 1979 in Allegheny Coun-
ty and Japan, and followed up until 2008 in the USA 
and 2005 in Japan, respectively (9,10).
The absolute mortality is found to be higher 
among males in all of the long-term studies, except 
for that from the USA (5,8-10). On the other hand, 
the relative mortality, represented by the standard-
ized mortality ratio (SMR), is female-dominated, 
only in Norway it is similar in both sexes (5,8-10). No 
difference in the mortality rate between sexes is ob-
served in the cohort from Israel and no data exists 
regarding the relative mortality in the same popula-
tion (23). Especially high is the overall SMR in Japan 
- 10.7, and that in Allegheny County is 6.9 (9,10). The 
relative mortality is found to be lower in Norway, 
Finland, and Israel - overall SMR 4, 3.6, and 2.98, re-
spectively (8,5,23). 
Lower all-cause mortality is observed in two 
short-term studies from Wales and Northern Ireland 
(subjects followed until 2015 and 2012, respective-
ly) - 0.7/1000 in Wales and 1.5/1000 in Northern Ire-
land (25,26). It is found to exceed almost 3 times the 
mortality rate of the general population (overall SMR 
2.91 and 2.96 in Wales and Northern Ireland, respec-
tively). The SMR is again female-dominated, while 
the absolute mortality is shown to be higher in males 
in Wales and similar for both sexes in Northern Ire-
land. The mortality registered by Dahlquist et al. in 
Sweden (the country with the second highest inci-
dence of T1D in the world) is 0.96/1000 for the sub-
jects diagnosed between 1977 and 2000 and followed 
up for a mean time of 8 years (24). Similar to most 
of the other studies, the SMR of 2.15 is significant-
ly higher in females (p=0.045), but it is lower com-
pared with the SMR in the rest of the Scandinavian 
countries (24,5,8). However, the follow-up period of 
the T1D subjects in this study is substantially shorter.
It is noteworthy that the mortality is especial-
ly high in Japan, as mentioned above, a country with 
one of the lowest incidences of T1D in the world 
(more than 20 times lower than that in Finland) (28). 
The first report of the DERI observational study in 
1991 demonstrated that Japanese patients with T1D 
had a much worse prognosis than did similar pa-
tients in Finland, the USA, and Israel, with the most 
frequent causes of death being the acute complica-
tions of diabetes and end-stage renal disease (ESRD) 
(29-31). A possible reason discussed for the higher 
mortality rate in Japan is the low incidence of T1D 
itself in this country, which probably causes difficul-
ties in the diagnosis and treatment of the disease. On 
the other hand, the EURODIAB study shows no sig-
nificant relationship of mortality with the country’s 
incidence rate or gross domestic product (7).
Much higher is also the number of deaths in 
the cohort from the USA in comparison with the Eu-
ropean countries from the population-based stud-
ies included. The significant impact of the disease 
on the overall mortality is demonstrated by the high 
SMR of 6.9, compared with the European countries, 
where the SMR varies between 2 and 4 (9,5,8,24-26). 
These geographical differences could be due to the 
high-cost healthcare in the USA, which is probably 
an obstacle for a frequent contact of some patients 
with a physician. Another possible reason could be 
the higher mortality rate in African Americans (a 
part of the population in Allegheny County) (9,14). 
Time Trends in Mortality (Impact of Year of 
Diagnosis on Mortality)
The influence of calendar year of diagnosis on 
mortality is examined in the population-based stud-
ies from Norway, Finland, Japan, and the USA. No 
significant difference in cumulative survival is found 
in Norway when the cases diagnosed between 1978 
and 1982 are compared over 20 years of disease du-
ration with those diagnosed between 1973 and 1977 
(0.96 vs 0.97, p=0.52) (8). Another population-based 
Norwegian study including childhood-onset T1D 
subjects diagnosed in 1973-1982 and 1989-2012, and 
followed up until 2013, shows more contemporary 
data (32). Temporal trends in mortality assessed by 
cox regression analysis show that it decreased signifi-
cantly by 49% (HR 0.51, 95% CI 0.28-0.93; p=0.03) for 
those diagnosed in 1999-2012 compared with sub-
jects diagnosed in 1973-1982. However, the follow-
up time of both groups is different. Improved surviv-
al of patients with later calendar year of diagnosis is 
also observed by Harjutsalo et al. in Finland (5). The 
20-year cumulative mortality in the groups of pa-
tients diagnosed in 1970-1974, 1975-1979, 1980-1984, 
and 1985-1989 is 4.7% (3.7% to 5.8%), 4.3% (3.3% to 
5.2%), 3.6% (2.8% to 4.5%), and 2.7% (1.9% to 3.4%), 
respectively. However, the follow-up time of the last 
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group has not yet reached 20 years. In the same co-
hort, SMR decreases by 4.3% per year of diagnosis, 
after adjustment for duration and age at onset of di-
abetes. Furthermore, an improvement in mortality 
due to chronic complications is observed - a signifi-
cant decline from 10.0 (5.8 to 13.1)/10 000 in patients 
diagnosed in 1970-1974 to 2.2 (0.9 to 4.5)/10 000 in 
those diagnosed in 1985-1989 (p<0.001). On the oth-
er hand, mortality due to acute complications (non-
alcohol related) shows a non-significant tendency 
to increase from 2.1 (0.8 to 4.6)/10 000 to 4.1 (1.9 to 
6.5)/10 000.
Noticeable is the improvement in T1D mor-
tality in Japan. The 15-year survival increases from 
87.6% for the subjects diagnosed in 1965-1969 to 96% 
for those diagnosed in 1975-1979 (33). This benefi-
cial influence of the calendar year of diagnosis is pre-
served even for longer period of follow-up. SMR ob-
served at the 25th year of follow-up declines from 
19.3 in the 1965-1969 diagnosis group to 6.6 in the 
1975-1979 diagnosis group (10). Improvement in pa-
tient prognosis is also observed in the representa-
tive cohort from the USA with T1D onset after 1965-
1969. Significantly higher mortality rates from dia-
betes-related causes are registered for the 1965-1969 
cohort in comparison with the 1975-1979 cohort (RR 
1.5, р=0.05). In addition, further analysis by diabe-
tes duration reveals that the 1975-1979 cohort has a 
significantly lower mortality rate compared with the 
1965-1969 diagnosis group over the first 20 years of 
disease duration (RR 0.45, р=0.01) (14).
Unlike Finland and the USA, where overall 
mortality rates continue to rise, as would be expect-
ed with increasing age and T1D duration, in Japan 
the overall mortality rates decline with longer peri-
od of follow-up (11, 34). This is further an indicator 
of the dramatic improvements in T1D care in Japan 
after 1980. 
Effect of Age at Onset of T1D on Mortality
Three of the long-term studies included in the 
present review assess the effect of age at diabetes on-
set on overall mortality. Skrivarhaug et al. find a sig-
nificantly higher mortality rate in individuals with 
diabetes onset at age 10-14 years in Norway than in 
those with onset below 10 years of age (2.85/1000 vs 
1.73/1000; RR 1.70, 95% CI 1.15-2.51) (8). A similar 
tendency is observed in Finland and Japan regarding 
T1D patients diagnosed in 1965-1979 and followed 
up until 1994 (2 of the cohorts in the DERI study, 11). 
It is found that the absolute mortality is almost two 
times higher in patients with diabetes onset at puber-
tal age (≥11 years for girls, ≥12 years for boys) than 
in those with diagnosis in prepubertal age (9.41/1000 
vs 4.56/1000 in Japan, 4.46/1000 vs 2.78/1000 in Fin-
land). The effect of diagnosis in pubertal age is no 
longer significant after adjustment for mortality in 
the corresponding age groups of the general popu-
lation. The SMR for pubertal and prepubertal age is 
16.4 (12.7-20.9) and 10.8 (8.4-13.6) in Japan, and 3.7 
(3.2-4.3) and 3.6 (3.1-4.3) in Finland, respectively. 
This is an expression of the higher mortality in pu-
bertal age in the general population as well.
Laron-Kenet et al. find no relationship between 
overall T1D mortality in Israel and age at diagnosis 
(under and over 12 years). However, the death of the 
patients diagnosed before 12 years of age occurred at 
a younger age than those diagnosed at 12 years or lat-
er (log-rank 5.8; p=0.016) (23). An effect of age at di-
agnosis on absolute mortality is also observed in the 
short-term study from Wales - higher mortality risk 
for those diagnosed in teenage years than those who 
developed T1D younger (OR per additional year of 
age 1.16 (1.05-1.28); p=0.005) (25).
Causes of Death
When studying the causes of death among T1D 
subjects in the long-term studies observed, the vio-
lent death (accidents, suicides, intoxications) appears 
to be the most common in the cohorts from Norway 
and Finland (for the diagnosed in 1970-1989 in Fin-
land), accounting for around 30% of all death cases 
(5, 8). They are followed by acute (22.6%) and chron-
ic diabetes complications (28.7%) in Finland, and 
acute complications (22.3%), sudden death (16.5%), 
and cardiovascular (CV) death (14.6%) in Norway. 
On the other hand, in the study from Israel, which 
is with a significantly shorter observational time, the 
leading mortality causes are DKA (21.6%), infections 
(21.6%), and chronic diabetes complications (24.3%) 
(23). The most common cause of death in the cohort 
from Allegheny County is CV mortality (36.2%), fol-
lowed by acute metabolic complications (16.13%), in-
fections (16%) and renal diseases (13.26%) (14). Most 
frequent for the Japanese population is the mortal-
ity due to ESRD (22.87%), followed by CV mortali-
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ty (17.94%), acute metabolic complications (17.04%), 
and infections (15.25%) (10).
Scrivarhaug et al. analyze the causes of death in 
T1D subjects in Norway according to age at death (8). 
They find acute metabolic complications (38%) and 
violent death (23%) to be the most common causes 
before the age of 20 years. The same two remain most 
frequent (28% and 33%, respectively) among subjects 
aged 20-30 years, while after the age of 30 years CV 
death is predominant (30%). The impact of disease 
duration on the causes of death has been studied in 
the same population. Dominant in the first 10 years 
of T1D are acute metabolic complications (42%), 
while after that - violent death (29%). Acute metabol-
ic complications (22%) turn out to be the second most 
common cause of death after 10-19 years and CV dis-
eases (26%) - after 20 years of diabetes duration. The 
influence of disease duration on the leading causes of 
death in T1D subjects is also assessed in the USA, Al-
legheny County, by Secrest et al. (14). Within the first 
10 years of diabetes onset, > 70% of all deaths are due 
to acute diabetes complications, while after 10 years 
of diabetes, the same become a minor but persistent 
(9–15%) cause of death in this population. On the 
other hand, after 10 years of diabetes, CV mortali-
ty becomes the leading cause of death, eventually ac-
counting for 40% of all deaths after 20 years of dura-
tion. Renal disease does not contribute to any deaths 
until after 10 years of diabetes duration, when it con-
tributes to about half of all deaths in the same cohort. 
Similar to the other population-based studies, acute 
diabetes complications are the most common cause 
of early mortality also in Japan (40% of the death 
cases followed for less than 10 years), while mortal-
ity due to ESRD dominates in the subjects with a lon-
ger follow-up time (10-19 years) (10). The percentage 
of CV death also increases with longer duration of 
T1D, becoming the leading mortality cause after 30-
35 years of observation.
A comparison between the causes of death 
among T1D subjects and the general population in 
Norway demonstrates about 20-fold higher mortal-
ity rates for ischemic heart disease (IHD) and cere-
brovascular disease for the patients with T1D, while 
SMR for violent death is significantly lower (3.3 for 
men, 1.7 for women) (8). ESRD is responsible for a 
small number (8%) of all deaths in the same study. 
Nevertheless, SMR is especially high for this cause - 
220 for males and 155 for females. In Finland, SMR 
for IHD is high, while that for cerebrovascular dis-
ease is significantly lower (17.4 and 5.1, respectively) 
(5). In Finland and Norway, the mortality from sui-
cide is not significantly greater in patients with di-
abetes compared with the general population (5,8). 
However, it accounts for 10-20% of all deaths. 
Similar are also the observations for the dia-
betic populations in Allegheny County (USA) and 
Japan - high SMR for CV diseases and renal dis-
eases, but also for infections (14, 10). On the other 
hand, deaths from non-diabetes-related causes oc-
cur at similar rates in T1D to the age-, sex-, and race-
matched general population (SMR for accidents/sui-
cides and neoplasms - 1.2 in the USA, 2.1 and 0.5 in 
Japan, respectively). 
DKA is the leading diabetes-related cause of 
death in the short-term studies from Wales, North-
ern Ireland, and Sweden (24-26). On the other hand, 
the chronic diabetes complications are responsible 
for a small percentage of mortality in these cohorts, 
which is most probably a result of the shorter follow-
up time and the relatively young age of the patients. 
It is worth noting that the so called dead-in-bed syn-
drome is the second most common cause of death 
among diabetic subjects in Sweden, comprising 22% 
of all deaths in this cohort (24). 
CONCLUSION
In conclusion, childhood-onset T1D is still as-
sociated with premature mortality even in societies 
with well-organized health care systems and unre-
stricted access to treatment of diabetes and its com-
plications. Higher is the absolute mortality among 
males in the majority of the population-based stud-
ies included in the review. On the other hand, the rel-
ative mortality is female-dominated in almost all the 
cohorts, thus demonstrating that diabetes greatly at-
tenuates, or may even reverse, the protective effect of 
female sex. Especially high is the mortality rate in Ja-
pan and the USA, unlike, for example, the Scandi-
navian countries, where the incidence of T1D is the 
highest. On the other hand, the dissimilarities in the 
study methods and the characteristics of the exam-
ined cohorts (including the longer period of follow-
up for the Allegheny County population) make com-
parisons difficult. There are common trends for lon-
ger survival with later calendar year of diagnosis and 
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for higher mortality with pubertal (compared with 
prepubertal) onset of disease in most of the long-term 
studies. The leading causes of death among T1D sub-
jects appear to be the acute and chronic diabetes com-
plications. However, in some cohorts a large number 
of death cases are also due to violent death, including 
suicides and intoxications. That should focus the at-
tention on the psychological health of childhood-on-
set T1D as well. The worldwide increase in incidence 
of the disease, as well as the continuous technologi-
cal progress in diabetology, raise the importance of 
conducting long-term contemporary mortality stud-
ies in order to establish the efficacy of T1D treatment 
over time.
The study is supported by a grant 13/3 from 
14.12.2017 from the Scientific Research Fund at 
the Ministry of Education and Science of Bulgaria 
and the Science Fund of the Medical University of 
Varna.
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